Literature DB >> 9630636

The presence of transthyretin in rat ependymal cells is due to endocytosis and not synthesis.

S Kuchler-Bopp1, M E Ittel, J B Dietrich, A Reeber, M Zaepfel, J P Delaunoy.   

Abstract

The presence and synthesis of transthyretin, a major carrier protein of thyroxine in rat cerebrospinal fluid, was investigated in choroid plexus epithelial cells and ependymal cells by immunocytochemistry, in situ hybridization, and analysis by Northern and Western blot using a specific oligonucleotide probe and a specific polyclonal antibody to transthyretin. Choroid plexus epithelial cells expressed transthyretin at high levels in developing rat cerebral hemispheres and in cultured cells. These cells secreted transthyretin into the cerebrospinal fluid. In the developing rat brain transthyretin was present in the cytoplasm of ependymal cells, in vesicles in contact with the apical membrane and in cilia. In ependymal cell cultures this protein was particularly abundant in the cilia of these cells. In contrast, ependymal cells did not synthesize transthyretin. It is postulated that transthyretin is transported to ependymal cells from the cerebrospinal fluid by endocytosis. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630636     DOI: 10.1016/s0006-8993(98)00154-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

Review 1.  Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route.

Authors:  Conrad E Johanson; John A Duncan; Edward G Stopa; Andrew Baird
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

2.  Toward a better understanding of the cellular basis for cerebrospinal fluid shunt obstruction: report on the construction of a bank of explanted hydrocephalus devices.

Authors:  Brian W Hanak; Emily F Ross; Carolyn A Harris; Samuel R Browd; William Shain
Journal:  J Neurosurg Pediatr       Date:  2016-04-01       Impact factor: 2.375

3.  Is Transthyretin a Regulator of Ubc9 SUMOylation?

Authors:  Elżbieta Wieczorek; Sylwia Kędracka-Krok; Katarzyna Sołtys; Urszula Jankowska; Rafał Hołubowicz; Justyna Seliga; Andrzej Ożyhar
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.